Immunomic Therapeutics, Inc.
Amendment
CIK: 0001543256·Biotechnology·DELAWARE·Filed: Jan 14, 2021
Total Offering
$77,728,230
Amount Sold
$77,728,230
Investors
6
First Sale
Feb 18, 2020
Offering Details
- Type
- Equity, Option to Acquire
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| WILLIAM G. HEARL | Related Person |
| C. ERIC WINZER | Related Person |
| MICHAEL D. LACK | Related Person |
| JAMES W. WISHART | Related Person |
| RONALD P. THIBOUTOT | Related Person |
| Yang Gon Jin | Related Person |
| HYUK JOO JEE | Related Person |
| ARLO MCGINN | Related Person |
| ALEX S KIM | Related Person |
Company
Immunomic Therapeutics, Inc.
ATTN: WILLIAM HEARL, 15010 BROSCHART RD.
ROCKVILLE, MD, 20850
301-728-0860
SEC Filing
0001543256-21-000001
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free